WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032874) POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032874    International Application No.:    PCT/US2000/030188
Publication Date: 10.05.2001 International Filing Date: 01.11.2000
Chapter 2 Demand Filed:    31.05.2001    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: CURAGEN CORPORATION [US/US]; 555 Long Wharf Drive, 11th Floor, New Haven, CT 06511 (US) (For All Designated States Except US).
PRAYAGA, Sudhirdas, K. [IN/US]; (US) (For US Only).
TAUPIER, Raymond, J. [US/US]; (US) (For US Only)
Inventors: PRAYAGA, Sudhirdas, K.; (US).
TAUPIER, Raymond, J.; (US)
Agent: ELRIFI, Ivor, R.; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C., One Financial Center, Boston, MA 02111 (US)
Priority Data:
60/162,992 01.11.1999 US
60/163,021 02.11.1999 US
60/163,861 05.11.1999 US
09/703,101 31.10.2000 US
Title (EN) POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME
(FR) NOUVEAUX POLYPEPTIDES ET ACIDES NUCLEIQUES LES CODANT
Abstract: front page image
(EN)The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invetion additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
(FR)La présente invention concerne de nouveaux polynucléotides NOVX isolés et des polypeptides codés par ces polynucléotides NOVX. Elle concerne également les anticorps qui se lient de manière immunospécifique à un polypeptide NOVX ou n'importe quel dérivé, variant, mutant ou fragment du polypeptide NOVX, de polynucléotide ou d'anticorps. L'invention concerne également des procédés dans lesquels les polypeptides, polynucléotides et anticorps NOVX s'utilisent pour la détection et le traitement d'une vaste gamme d'états pathologiques et ont également d'autres usages.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)